Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
about
Semi-nested real-time reverse transcription polymerase chain reaction methods for the successful quantitation of cytokeratin mRNA expression levels for the subtyping of non-small-cell lung carcinoma using paraffin-embedded and microdissected lung bimRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer.Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinomaAltered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes.Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes.Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyDisseminated Pancreatic Neuroendocrine Neoplasm (NEN) with an Uncommon Localisation in the Central Nervous System. A Case ReportLanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors.Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms.GIPR expression in gastric and duodenal neuroendocrine tumors.Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.Increased phosphorylation of ERK1/2 is associated with worse chemotherapeutic outcome and a poor prognosis in advanced lung adenocarcinoma.Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation.Neuropeptide G Protein-Coupled Receptors as Oncotargets.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Q34747336-314D1B94-106A-4D16-9D98-C170B140A76FQ35084849-AB11B6A2-7FFF-4933-9F1C-8EA5E4E3DC2CQ35143989-B74EF268-FFD0-43FE-9EFC-5665308CFF25Q35223889-20ABA286-0A07-4979-83B5-06310BB4664FQ35288725-02008100-7B43-4E31-9D55-2A2E13433F58Q36413831-C6AD8EE0-7ACE-4D3C-BBB0-20845538855CQ37691470-7C36B89A-3821-4435-9AFE-CB21292ADEC9Q38658730-EAF27BA5-D051-48A2-93D0-FEBC670FA781Q41496806-6CD57419-437C-4CFA-8CC8-39DA05B503F8Q42734654-CA98DA5F-0628-4698-A44D-301F8DD09F24Q48088751-E0C85B32-4A0B-4170-90DF-98F231C26864Q49352143-CB8F80BF-4847-4F6D-AB5A-57858D8FB250Q51562158-E511CC70-E198-43FC-8F0F-650480C9AAF2Q53233612-28109D46-7895-45BE-B0EF-F3927DFA89A0Q55709770-C87CA287-714D-41DD-AB8A-94CEBED5D3DFQ57144951-907DFB5F-199B-4C62-A1B1-535BA575466F
P2860
Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression of Somatostatin Rec ...... ethod and Immunohistochemistry
@ast
Expression of Somatostatin Rec ...... ethod and Immunohistochemistry
@en
type
label
Expression of Somatostatin Rec ...... ethod and Immunohistochemistry
@ast
Expression of Somatostatin Rec ...... ethod and Immunohistochemistry
@en
prefLabel
Expression of Somatostatin Rec ...... ethod and Immunohistochemistry
@ast
Expression of Somatostatin Rec ...... ethod and Immunohistochemistry
@en
P2093
P2860
P356
P1476
Expression of Somatostatin Rec ...... ethod and Immunohistochemistry
@en
P2093
Gou Mizutani
Noriko Watanabe
Norimichi Nemoto
Sumie Ohni
Taku Honma
Toshimi Seki
Yoko Nakanishi
Yukari Obana
P2860
P304
P356
10.1267/AHC.12006
P577
2012-05-25T00:00:00Z